HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

James E Egan Selected Research

Cytokines

1/2018IRX-2 natural cytokine biologic for immunotherapy in patients with head and neck cancers.
2/2012IRX-2, a novel biologic, favors the expansion of T effector over T regulatory cells in a human tumor microenvironment model.
9/2007IRX-2, a novel in vivo immunotherapeutic, induces maturation and activation of human dendritic cells in vitro.

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


James E Egan Research Topics

Disease

7Neoplasms (Cancer)
01/2018 - 10/2003
6Opioid-Related Disorders (Opiate Addiction)
03/2013 - 04/2009
3Squamous Cell Carcinoma of Head and Neck
01/2018 - 09/2007
3Substance-Related Disorders (Drug Abuse)
03/2011 - 03/2011
2Head and Neck Neoplasms (Head and Neck Cancer)
01/2018 - 06/2012
2Squamous Cell Neoplasms (Squamous Cell Cancer)
06/2012 - 06/2012
2Pain (Aches)
03/2011 - 04/2009
1Dyslipidemias (Dyslipidemia)
01/2022
1Hypertension (High Blood Pressure)
01/2022
1Viremia
01/2022
1Sexually Transmitted Diseases (Sexually Transmitted Disease)
02/2021
1Mental Disorders (Mental Disorder)
06/2020
1Acquired Immunodeficiency Syndrome (AIDS)
06/2020
1Opiate Overdose
01/2018
1Infections
12/2016
1Necrosis
06/2012
1Fibrosis (Cirrhosis)
06/2012
1Carcinogenesis
10/2011
1Marijuana Use
03/2011
1Chronic Pain
03/2011

Drug/Important Bio-Agent (IBA)

7IRX 2IBA
01/2018 - 09/2007
4Opioid Analgesics (Opioids)IBA
03/2013 - 03/2011
3CytokinesIBA
01/2018 - 09/2007
3Naloxone Drug Combination BuprenorphineFDA Link
03/2011 - 03/2011
2Buprenorphine (Subutex)FDA LinkGeneric
03/2011 - 04/2009
1Naloxone (Narcan)FDA LinkGeneric
01/2018
1Rilpivirine (TMC-278)IBA
12/2016
1Immunologic Factors (Immunomodulators)IBA
01/2016
1Coloring Agents (Dyes)IBA
06/2012
1Eosine Yellowish-(YS) (Eosin)IBA
06/2012
1Hematoxylin (Haematoxylon)IBA
06/2012
1Peptides (Polypeptides)IBA
10/2011
1AntigensIBA
10/2011
1EpitopesIBA
10/2011
1Cancer VaccinesIBA
10/2011
1VaccinesIBA
10/2011
1Neoplasm Antigens (Tumor Antigens)IBA
10/2011
1Amphetamine (Amfetamine)FDA LinkGeneric
03/2011
1Fibroblast Growth Factors (Fibroblast Growth Factor)IBA
10/2003
1IntegrinsIBA
10/2003

Therapy/Procedure

8Therapeutics
01/2022 - 09/2007
2Immunotherapy
01/2018 - 06/2012
1Condoms (Condom)
02/2021
1Injections
12/2016
1Neoadjuvant Therapy
06/2012